These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35906495)

  • 41. Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis.
    Moxey J; Huq M; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Ross L; Major G; Roddy J; Stevens W; Nikpour M
    Arthritis Res Ther; 2019 Feb; 21(1):57. PubMed ID: 30764870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Difficulties in the differential diagnosis of kidney injury in a patient with infective endocarditis associated with antineutrophil cytoplasmic antibodies].
    Androsova TV; Kozlovskaya LV; Taranova MV; Strizhakov LA; Gulyaev SV; Russkikh AV
    Ter Arkh; 2017; 89(6):84-88. PubMed ID: 28745694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
    Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis.
    Ono N; Inoue Y; Miyamura T; Ueda N; Nagano S; Inoue H; Oryoji K; Ota SI; Sawabe T; Yoshizawa S; Takeyama Y; Sadanaga Y; Takamori A; Kimoto Y; Miyake K; Horiuchi T; Nakashima H; Niiro H; Tada Y
    J Rheumatol; 2021 Mar; 48(3):417-425. PubMed ID: 31523048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Ahn SS; Pyo JY; Song JJ; Park YB; Lee SW
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454396
    [No Abstract]   [Full Text] [Related]  

  • 46. PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab.
    van Dam LS; Dirikgil E; Bredewold EW; Ray A; Bakker JA; van Kooten C; Rabelink TJ; Teng YKO
    Nephrol Dial Transplant; 2021 Jul; 36(8):1408-1417. PubMed ID: 32601673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of infective endocarditis mimicking antineutrophil cytoplasmic antibody-associated vasculitis.
    Doi K; Minami K; Ishigami K; Ikeda S; Hamatani Y; Yoshizawa T; Ide Y; Fujino A; Ishii M; Iguchi M; Ogawa H; Masunaga N; Abe M; Akao M
    J Cardiol Cases; 2022 Jul; 26(1):32-34. PubMed ID: 35923533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
    Chang DY; Li ZY; Chen M; Zhao MH
    Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    McDermott G; Fu X; Stone JH; Wallwork R; Zhang Y; Choi HK; Wallace ZS
    JAMA Intern Med; 2020 Jun; 180(6):870-876. PubMed ID: 32282021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Micheletti RG; Chiesa Fuxench Z; Craven A; Watts RA; Luqmani RA; Merkel PA;
    Arthritis Rheumatol; 2020 Oct; 72(10):1741-1747. PubMed ID: 32419292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Results from a French Retrospective Monocentric Cohort.
    Deshayes S; Martin Silva N; Grandhomme F; Khoy K; Mariotte D; Boutemy J; Maigné G; Brière-Bellier C; Delmas C; Bienvenu B; Lobbedez T; de Boysson H; Aouba A
    J Rheumatol; 2019 Nov; 46(11):1502-1508. PubMed ID: 30824651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 Patients.
    Lhote R; Chilles M; Groh M; Puéchal X; Guilpain P; Ackermann F; Amoura Z; Annesi-Maesano I; Barba T; Catherinot E; Cohen-Aubart F; Cohen P; Cottin V; Couderc LJ; De Boysson H; Delbrel X; Dominique S; Duhaut P; Fain O; Hachulla E; Hamidou M; Kahn JE; Legendre C; Le Quellec A; Lhote F; Lifermann F; Mathian A; Néel A; Nunes H; Subra JF; Terrier B; Mouthon L; Diot E; Guillevin L; Brillet PY; Tcherakian C;
    J Rheumatol; 2020 Oct; 47(10):1522-1531. PubMed ID: 31787599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis.
    Kwon M; Lee AS; Mira-Avendano I; Rojas CA; Grage R; Abril A
    J Clin Rheumatol; 2021 Dec; 27(8):324-330. PubMed ID: 32251058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
    Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ
    Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies.
    Bossuyt X; Rasmussen N; van Paassen P; Hellmich B; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Csernok E; Damoiseaux J
    Rheumatology (Oxford); 2017 Sep; 56(9):1533-1541. PubMed ID: 28541581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study.
    Liao QQ; Ren YF; Zhu KW; Qin D; Mo YJ; Cong S; Wu J; Wang CY; Cui XJ; Xu HZ; Guo LZ; Zhang YY; Song HX; Zhang W; Yang Z; Tang YF; Li ZJ; Xie ZN; Li LM; Wang HJ; Zhou MM; Wei FN; Chen P; Shi YH
    Front Immunol; 2022; 13():913667. PubMed ID: 35844610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder DR; Kabat BF; Langford CA; Kallenberg CGM; Seo P; Spiera RF; St Clair EW; Fervenza FC; Stone JH; Monach PA; Specks U; Merkel PA;
    J Autoimmun; 2019 Dec; 105():102302. PubMed ID: 31320177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis.
    Rathmann J; Stamatis P; Jönsson G; Englund M; Segelmark M; Jayne D; Mohammad AJ
    Rheumatology (Oxford); 2022 Nov; 61(12):4817-4826. PubMed ID: 35289842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infective endocarditis by Bartonella quintana masquerading as antineutrophil cytoplasmic antibody-associated small vessel vasculitis.
    Sugiyama H; Sahara M; Imai Y; Ono M; Okamoto K; Kikuchi K; Nagai R
    Cardiology; 2009; 114(3):208-11. PubMed ID: 19602882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
    Hilhorst M; van Paassen P; Tervaert JW;
    J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.